Josh Nebo

CC
Zalgiris Kaunas
Recovers from illness
CZalgiris Kaunas
January 7, 2022
Nebo (illness) put up six points and six rebounds over 18 minutes off the bench in Friday's domestic game.
ANALYSIS
Nebo sat out Zalgiris' previous domestic contest with an illness, but that was the only game he wound up missing. Nebo did not play as many minutes Friday as he is averaging this season, but he came pretty close, so it seems likely he will be back at full speed in Zalgiris' next EuroLeague game Tuesday against Bayern.
Read More News
Per Game
Total
Per 36
EuroLeague Per Game Stats
Loading Per Game Stats...
EuroLeague Total Stats
Loading Total Stats...
EuroLeague Per 36 Stats
Loading Per 36 Stats...
2021
Game Log
Calculate Stats Over Time
Just click on any two dates.
Scoring
DraftKings
Dream11
Loading Game Log...
Zalgiris Kaunas Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
More Fantasy News
Out with illness
CZalgiris Kaunas
Illness
January 2, 2022
Nebo did not suit up for Sunday's domestic game due to an illness, according to Zalgiris' official Twitter account.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Back at full speed
CZalgiris Kaunas
December 2, 2021
Nebo scored 10 points and grabbed six rebounds over 28 minutes in Thursday's victory over Baskonia.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Will suit up Tuesday
CZalgiris Kaunas
November 16, 2021
Nebo (ankle) will be available for Tuesday's game against Panathinaikos, according to Zalgiris' official Twitter account.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Could return Tuesday
CZalgiris Kaunas
Ankle
November 15, 2021
Nebo (ankle) could return to action Tuesday against Panathinaikos, according to Zalgiris' official website.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Will not play in Round 9
CZalgiris Kaunas
Ankle
November 12, 2021
Nebo will not play Friday against Real Madrid due to an ankle injury, according to BasketNews.com.
ANALYSIS
Subscribe now to instantly reveal our take on this news.